Literature DB >> 17407641

Efficacy of a paracetamol and caffeine combination in the treatment of the key symptoms of primary dysmenorrhoea.

Z Ali1, I Burnett, R Eccles, M North, M Jawad, S Jawad, G Clarke, I Milsom.   

Abstract

OBJECTIVE: Primary dysmenorrhoea is characterised by pain, cramping and backache at the time of menses. Despite the high prevalence of dysmenorrhoea, few sufficiently powered, placebo-controlled studies have examined the efficacy of over the counter analgesics in this condition. Furthermore, even fewer studies have directly examined the efficacy of analgesics on specific dysmenorrhoea symptoms. Research design and main outcome measures: This was a single-dose, placebo-controlled, double blind, crossover study carried out in 320 women with moderate-to-severe dysmenorrhoea pain. At 2 h following dosing, 1 g paracetamol plus 130 mg caffeine led to significantly greater pain relief compared to 1 g paracetamol alone (p < 0.05), 130 mg caffeine alone (p < 0.01) or placebo (p < 0.01). The combination was also significantly more effective in relieving abdominal cramping and backache compared to the other treatment arms. No major treatment related adverse events were reported during this study.
CONCLUSIONS: When taken at recommended doses, both paracetamol and the combination of paracetamol and caffeine are safe and effective treatments for primary dysmenorrhoea. Consistent with results from other acute pain states, caffeine acts as an analgesic adjuvant and enhances the efficacy of paracetamol.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17407641     DOI: 10.1185/030079907x182239

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  7 in total

Review 1.  Paracetamol (acetaminophen) for chronic non-cancer pain in children and adolescents.

Authors:  Tess E Cooper; Emma Fisher; Brian Anderson; Nick Mr Wilkinson; David G Williams; Christopher Eccleston
Journal:  Cochrane Database Syst Rev       Date:  2017-08-02

2.  Psychometric validation of the dysmenorrhea daily diary (DysDD): a patient-reported outcome for dysmenorrhea.

Authors:  Allison M Nguyen; Rob Arbuckle; Tjeerd Korver; Fang Chen; Beverley Taylor; Alice Turnbull; Josephine M Norquist
Journal:  Qual Life Res       Date:  2017-04-12       Impact factor: 4.147

Review 3.  Combined analgesics in (headache) pain therapy: shotgun approach or precise multi-target therapeutics?

Authors:  Andreas Straube; Bernhard Aicher; Bernd L Fiebich; Gunther Haag
Journal:  BMC Neurol       Date:  2011-03-31       Impact factor: 2.474

4.  A qualitative study to develop a patient-reported outcome for dysmenorrhea.

Authors:  Allison Martin Nguyen; Louise Humphrey; Helen Kitchen; Tayyaba Rehman; Josephine M Norquist
Journal:  Qual Life Res       Date:  2014-07-22       Impact factor: 4.147

Review 5.  Caffeine as an analgesic adjuvant for acute pain in adults.

Authors:  Christopher J Derry; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2014-12-11

Review 6.  New developments in the pharmacotherapy of neuropathic chronic pelvic pain.

Authors:  Erin T Carey; Sawsan As-Sanie
Journal:  Future Sci OA       Date:  2016-10-05

Review 7.  Efficacy and safety of acetaminophen and caffeine for the management of acute dental pain: A systematic review.

Authors:  Youssef S Abou-Atme; Marcello Melis; Khalid H Zawawi
Journal:  Saudi Dent J       Date:  2019-04-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.